Abstract
Summary
We evaluated the impact of a more intensive version of an existing post-fracture coordinator-based fracture prevention program and found that the addition of a full-risk assessment improved treatment rates. These findings provide additional support for more intensive programs aimed at reducing the risk of re-fractures.
Introduction
Evidence-based guidelines support coordinator-based programs to improve post-fracture osteoporosis guideline uptake, with more intensive programs including bone mineral density (BMD) testing and/or treatment being associated with better patient outcomes. The purpose of this study was to evaluate the impact of a more intensive version (BMD “fast track”) of an existing provincial coordinator-based program.
Methods
We compared two versions of the program that screened treatment naïve fragility fracture patients (>50 years). Cases came from the BMD fast track program that included full fracture risk assessment and communication of relevant guidelines to the primary care provider (PCP). Matched controls were selected from the usual care program matching according to age, sex, fracture type, and date. Two matching techniques were used: traditional (hard) matching (TM) and propensity score matching (PS). The outcomes were treatment initiation with bone sparing medication, BMD testing rate, and the rate of returning to discuss the test results with a PCP.
Results
The program improvements led to a significant improvement in treatment initiation within 6 months from 16 % (controls based on PS) or 21 % (controls based on TM) to 32 % (cases). Ninety percent of patients in the BMD fast track program returned to their PCP to discuss bone health in the cases versus 60 % of the controls (for TM and PS). BMD testing occurred in 96 % of cases compared to the 66 (TM) or 65 % (PS) of the matched controls.
Conclusions
Addition of a full-risk assessment to a coordinator-based program significantly improved treatment rates within 6 months of screening.
Similar content being viewed by others
References
Kanis JA, Johnell O, De LC, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382
Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570–578
Bogoch ER, Elliot-Gibson V, Escott BG, Beaton DE (2008) The osteoporosis needs of patients with wrist fracture. J Orthop Trauma 22:S73–S78
Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305
Morrish DW, Beaupre LA, Bell NR, Cinats JG, Hanley DA, Harley CH, Juby AG, Lier DA, Maksymowych WP, Majumdar SR (2009) Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trial. Arthritis Rheum 61:209–215
Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG, Hochberg MC, McClung MR, Schnitzer TJ (2003) Pins and plaster aren’t enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 88:3482–3486
Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J (2003) Underuse of osteoporosis medications in elderly patients with fractures. Am J Med 115:398–400
Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR, Eisman JA, March L, Seibel MJ (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393–406
Sale JE, Beaton D, Posen J, Elliot-Gibson V, Bogoch E (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22:2067–2082
Dell R, Greene D (2010) Is osteoporosis disease management cost effective? Curr Osteoporos Rep 8:49–55
Majumdar SR, Lier DA, Leslie WD (2013) Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial. Journal of Clinical Endocrinology & Metabolism 98:1991–2000
Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG, Bell NR, Morrish DW (2009) Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169:25–31
Majumdar SR, Johnson JA, Lier DA, Russell AS, Hanley DA, Blitz S, Steiner IP, Maksymowych WP, Morrish DW, Holroyd BR, Rowe BH (2007) Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int 18:261–270
McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L, Adekunle F, Roberts D (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083–2098
Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90:1197–1205
Beaton DE, Sujic R, Jiang D, Sale J, Bogoch E (2009) Outcomes of the province-wide Post Fracture Osteoporosis Screening Program. American Society for Bone and Mineral Research, 31st Annual Meeting, Denver, Colorado
Beaton DE, Sujic R, McIlroy BK, Sale J, Elliot-Gibson V, Bogoch ER (2012) Patient perceptions of the path to osteoporosis care following a fragility fracture. Qual Health Res 22:1647–1658
Beaton DE, Dyer S, Jiang D, Slater M, Sale JEM, Bogoch E (2014) Factors influencing the pharmacological management of osteoporosis after a fragility fracture: results from the Ontario osteoporosis strategy’s fracture clinic screening program. Osteoporos Int 25:289–296
Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864–1873
Beaton DE, Mamdani M, Zheng H, Jaglal S, Cadarette SM, Jain R, et al. (2013) Impact of a case finding intervention on fracture risk reduction outcomes following fragility fractures. Presented at The 2nd Fragility Fracture Network Global Congress. Berlin, Germany
Yong JH, Masucci L, Hoch JS, Sujic R, Beaton D (2016) Cost-effectiveness of a fracture liaison service: a real-world evaluation after 6 years of service provision. Osteoporos Int 27(1):231–40. doi:10.1007/s00198-015-3280-1
Sujic R, Gignac MA, Cockerill R, Beaton DE (2013) Factors predictive of the perceived osteoporosis-fracture link in fragility fracture patients. Maturitas 76:179–184
Baim S, Leslie WD (2012) Assessment of fracture risk. Current Osteoporosis Reports 10:28–41
Lentle B, Cheung AM, Hanley DA, Leslie WD, Lyons D, Papaioannou A, Atkinson S, Brown JP, Feldman S, Hodsman AB, Jamal AS, Josse RG, Kaiser SM, Kvern B, Morin S, Siminoski K (2011) Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J 62:243–250
Austin PC (2008) A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 27:2037–2049
Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41–55
Stuart EA (2010) Matching methods for causal inference: a review and a look forward. Stat Sci 25:1–21
Glynn RJ, Schneeweiss S, Sturmer T (2006) Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol 98:253–259
Rosenbaum PR, Rubin DB (1985) Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. American Statistical Association 39:33–38
Ury HK (1975) Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data. Biometrics 31:643–649
Huntjens KM, Kosar S, van Geel TA, Geusens PP, Willems P, Kessels A, Winkens B, Brink P, van Helden S (2010) Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int 21(12):2075–82. doi:10.1007/s00198-010-1178-5
Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley D, Hodsman A, Jamal SA, Josse RG, Kaiser SM, Kvern B, Siminoski K, Leslie WD, for the Scientific Advisory Council of Osteoporosis Canada (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Backgroud and Technical Report
Cadarette SM, Jaglal SB, Raman-Wilms L, Beaton DE, Paterson JM (2010) Osteoporosis quality indicators using healthcare utilization data. Osteoporos Int 22:1335–1342
Tinetti ME, Gordon C, Sogolow E, Lapin P, Bradley EH (2006) Fall-risk evaluation and management: challenges in adopting geriatric care practices. Gerontologist 46:717–725
Rozental TD, Makhni EC, Day CS, Bouxsein ML (2008) Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. J Bone Joint Surg Am 90:953–961
Acknowledgments
The authors would like to acknowledge the fracture prevention coordinators, the regional integration leads, and the staff of Osteoporosis Canada for their implementation of the program changes evaluated in this study and for their feedback on our evaluation results. We thank all the patients who are part of this program as well as their orthopedic surgeons and primary care providers. Finally, we acknowledge the other members of the Fracture Clinic Screening Program (FCSP) evaluation team who provided constant feedback and reflection on all of our common evaluative efforts.
This study has been supported through funding by the Ontario Ministry of Health and Long-Term Care through the Ontario Osteoporosis Strategy. The views expressed are those of the authors and do not necessarily reflect those of the ministry.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
Beaton DE, Vidmar M, Pitzul KB, Sujic R, Rotondi NK, Sale JME, Jain R, and Weldon J declare that they have no conflicts of interest. Bogoch E reports unrestricted research grants from Amgen Canada Inc. and Clifford Martin and speaker fees from Amgen Canada Inc.
Rights and permissions
About this article
Cite this article
Beaton, D.E., Vidmar, M., Pitzul, K.B. et al. Addition of a fracture risk assessment to a coordinator’s role improved treatment rates within 6 months of screening in a fragility fracture screening program. Osteoporos Int 28, 863–869 (2017). https://doi.org/10.1007/s00198-016-3794-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-016-3794-1